Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery

Annals of Pharmacotherapy

Volumn 43, Issue 7-8, 2009, Pages 1197-1202

  Paciullo, Christopher A ^a   Short, Marintha R ^b   Steinke, Douglas T ^c   Jennings, Heath R ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Saint Joseph Hospital Lexington   (United States)

^c University of Kentucky   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cardiothoracic surgery; Coronary artery bypass grafting; Intensive care unit; Nicotine replacement therapy

Indexed keywords

NICOTINE PATCH;

ADULT; AGED; ANAMNESIS; APACHE; ARTICLE; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PRESCRIPTION; PRIORITY JOURNAL; SURGICAL MORTALITY; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

AGED; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 67651120053     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L423     Document Type: Article

References (24)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-146.
2. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-3138
3. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994;154:989-995 (Pubitemid 24144874)
4. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Nicotine-replacement therapy with use of a transdermal nicotine patch - a randomized double-blind placebo-controlled trial. Mayo Clin Proc 1990;65:1529-1537
5. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-1798
6. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007;131: 446-452
7. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-315
8. Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998;12: 239-244 (Pubitemid 28416489)
9. Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest 2004;125:435-438
10. Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med 2007;35:1517-1521 (Pubitemid 46809315)
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829
12. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006; 47:236-265 (Pubitemid 43005196)
13. The Joint Commission. Comprehensive review of hospital core measures. www.jointcommission.org/PerformanceMeasurement/Performance Measurement. February 24, 2008 (accessed 2008 May 2).
14. Sauer WH, Berlin JA, Strom BL, Miles C, Carson JL, Kimmel SE. Cigarette yield and the risk of myocardial infarction in smokers. Arch Intern Med 2002;162:300-306 (Pubitemid 34127407)
15. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-944 (Pubitemid 30191921)
16. Bradley F, Cupples ME. Reducing the risk of recurrent coronary heart disease. We know a bit more about what doesn't work. BMJ 1999;318:1499-1500 (Pubitemid 29255787)
17. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-1330
18. Anfossi G, Trovati M. Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur J Clin Invest 1996;26:353-370 (Pubitemid 26171949)
19. Krupski WC, Olive GC, Weber CA, Rapp JH. Comparative effects of hypertension and nicotine on injury-induced myointimal thickening. Surgery 1987;102:409-415
20. Kox M, Hoedemaekers AW, Pickkers P, van der Hoeven JG, Pompe JC. A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapy. Crit Care Med 2007;35:2468-9; author reply 2469. (Pubitemid 47476278)
21. Honisett TD. Nicotine replacement therapy for smokers admitted to intensive care. Intensive Crit Care Nurs 2001;17:318-321
22. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-1431 (Pubitemid 27272432)
23. Meine TJ, Patel MR, Washam JB, Pappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005;95:976-978
24. Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2007;3:CD001837.